Please login to the form below

Not currently logged in
Email:
Password:

Astellas picks Dr Charlotte Kremer to lead new medical affairs organisation

She joins the pharma company from Pfizer to take up a new global role

Astellas Dr Charlotte KremerDr Charlotte Kremer has moved from Pfizer to Astellas to lead the Japanese pharma company's new global medical affairs organisation.

Based at Astellas' Illinois headquarters for its Americas operations, Dr Kremer will be tasked with providing “global leadership for medical excellence and a unified medical perspective”.

The company's Global Medical Affairs unit is one of its newest organisations and, although based in the US, may work with a variety of supporting positions from across the regions in which Astellas is active.

"We are thrilled to have Charlotte join Astellas. She brings years of experience and an outstanding reputation to this new, global leadership role," said Yoshihiko Hatanaka, president and CEO of Astellas Pharma Inc., the parent company of Astellas US LLC.

"Further globalising our key functions, such as medical affairs, is a top priority at Astellas because of the value it brings to the company in this competitive global business environment."

Dr Kremer has spent 20 years in the pharmaceutical industry, most recently serving at Pfizer as VP and therapeutic area head for ophthalmology, PVD, rare diseases and neuroscience.

Prior to joining Pfizer she worked at Organon in the Netherlands and the US, providing medical support, developing phase IIIb/IV clinical trials and initiated and developed a medical liaison programme.

23rd February 2012

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics